1992年の透析療法の一般状況 : 最新の統計データ

概要

論文の詳細を見る
Since the beginning of dialysis as a routine therapy for patients with end stage renal failure, the vast majority of patients is treated with cellulosic dialysis membranes (83%). Synthetic polymers as membrane materials, although available since about 20 years, represent only a respectable portion of 17% worldwide. In contrast to stagnating transplantation rates, the dialysis patient population is increasing with yearly 5 to 7%.<BR>When comparing the three major dialysis markets, Japan, Europe and the U. S. A., differences exist between patients mortality rates. Best survival is achieved in Japan and Europe when set in contrast to data from the U. S.. Results may be explained with specific treatment modalities. Treatment time is longer, dialyser surface area is larger and dialyser re-use is not the dominating practice in these countries with these parameters contributing fundamentally to dialysis adequacy.
日本膜学会の論文